Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges

Theranostics(2020)10.7150/thno.51471Source: DataRank Database

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges is a research paper published in Theranostics (2020). On theSindex it has a DataRank of 0. It has been cited 129 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access129 citations

Download PDF

Cite:

Linked data & code

gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 6.92)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Philip Prathipati ORCID,Bakrudeen AA. Abdul,Srinivas Chava,Santharam S. Katta ORCID,Subash Gupta

Live enrichment

PubMed:33391502 PMC:PMC7738845 OpenAlex:https://openalex.org/W3097853370

NCI NIH HHS

Grant: 1K22CA197074

NCI NIH HHS

Grant: K22 CA197074

NCI NIH HHS

Grant: P30 CA036727

FWCI

6.92

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.thno.org/v11p0731.pdf

publisherhttps://www.thno.org/v11p0731.pdf

publisherhttps://www.thno.org/v11p0731.htm

journalhttps://doi.org/10.7150/thno.51471

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33391502

Fields of Study

COVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesEconomic and Financial Impacts of CancerAntineoplastic AgentsCOVID-19ComorbidityDrug RepositioningGenome, ViralHumansNeoplasmsPandemicsSARS-CoV-2Signal TransductionCOVID-19 Drug Treatment

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAntineoplastic AgentsHumansNeoplasmsSignal TransductionComorbidityGenome, ViralDrug RepositioningPandemics

Keywords

PandemicDiseaseMedicineCoronavirus disease 2019 (COVID-19)ComorbidityCancerOutbreakCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineInternal medicineInfectious disease (medical specialty)VirologyInflammationCoronavirusesCovid-19Sars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being